FI953423A - Temotsolomidin tehostaminen ihmisten kasvainsoluissa - Google Patents

Temotsolomidin tehostaminen ihmisten kasvainsoluissa Download PDF

Info

Publication number
FI953423A
FI953423A FI953423A FI953423A FI953423A FI 953423 A FI953423 A FI 953423A FI 953423 A FI953423 A FI 953423A FI 953423 A FI953423 A FI 953423A FI 953423 A FI953423 A FI 953423A
Authority
FI
Finland
Prior art keywords
temozolomide
enhancement
tumor cells
human tumor
human
Prior art date
Application number
FI953423A
Other languages
English (en)
Swedish (sv)
Other versions
FI953423A0 (fi
Inventor
John Colin Baer
Azadeh Alison Freeman
Edward Stuart Newlands
Amanda Jean Watson
Joseph Anthony Rafferty
Geoffrey Paul Margison
Original Assignee
Cancer Res Campaign Tech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cancer Res Campaign Tech filed Critical Cancer Res Campaign Tech
Publication of FI953423A0 publication Critical patent/FI953423A0/fi
Publication of FI953423A publication Critical patent/FI953423A/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
FI953423A 1993-01-14 1995-07-13 Temotsolomidin tehostaminen ihmisten kasvainsoluissa FI953423A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US475493A 1993-01-14 1993-01-14
PCT/GB1994/000065 WO1994015615A1 (en) 1993-01-14 1994-01-13 Potentiation of temozolomide in human tumour cells

Publications (2)

Publication Number Publication Date
FI953423A0 FI953423A0 (fi) 1995-07-13
FI953423A true FI953423A (fi) 1995-08-23

Family

ID=21712364

Family Applications (1)

Application Number Title Priority Date Filing Date
FI953423A FI953423A (fi) 1993-01-14 1995-07-13 Temotsolomidin tehostaminen ihmisten kasvainsoluissa

Country Status (20)

Country Link
EP (2) EP0922458A1 (fi)
JP (1) JPH08505615A (fi)
KR (1) KR100352046B1 (fi)
CN (1) CN1277541C (fi)
AU (1) AU5838494A (fi)
CA (1) CA2153775C (fi)
CZ (1) CZ286550B6 (fi)
FI (1) FI953423A (fi)
HU (1) HUT72665A (fi)
IL (1) IL108328A (fi)
MX (1) MX9400434A (fi)
MY (1) MY116474A (fi)
NO (1) NO952781L (fi)
PL (1) PL175842B1 (fi)
RU (1) RU2148401C1 (fi)
SK (1) SK282452B6 (fi)
TW (1) TW414710B (fi)
UA (1) UA29466C2 (fi)
WO (1) WO1994015615A1 (fi)
ZA (1) ZA94248B (fi)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5731304A (en) * 1982-08-23 1998-03-24 Cancer Research Campaign Technology Potentiation of temozolomide in human tumour cells
US5942247A (en) * 1996-07-31 1999-08-24 Schering Corporation Method for treating pediatric high grade astrocytoma including brain stem glioma
US5939098A (en) * 1996-09-19 1999-08-17 Schering Corporation Cancer treatment with temozolomide
US6251886B1 (en) 1998-12-07 2001-06-26 Schering Corporation Methods of using temozolomide in the treatment of cancers
WO2000033823A2 (en) * 1998-12-07 2000-06-15 Schering Corporation Methods of using temozolomide in the treatment of cancers
US6465448B1 (en) * 1999-08-13 2002-10-15 Case Western Reserve University Methoxyamine potentiation of temozolomide anti-cancer activity
US6635677B2 (en) 1999-08-13 2003-10-21 Case Western Reserve University Methoxyamine combinations in the treatment of cancer
SG161101A1 (en) * 2002-02-22 2010-05-27 Schering Corp Pharmaceutical formulations of antineoplastic agents, in particular temozolomide processes of making and using the same
WO2003101474A1 (en) * 2002-05-31 2003-12-11 Transmolecular, Inc. Combination chemotherapy with chlorotoxin
CN100350975C (zh) * 2005-02-03 2007-11-28 山东蓝金生物工程有限公司 抗癌药物组合物
CN100350974C (zh) * 2005-02-03 2007-11-28 山东蓝金生物工程有限公司 一种抗癌药物组合物
CN100431605C (zh) * 2005-02-03 2008-11-12 山东蓝金生物工程有限公司 一种抗癌药物组合物
CN100402091C (zh) * 2005-02-03 2008-07-16 山东蓝金生物工程有限公司 一种抗癌药物组合物
GB0502573D0 (en) * 2005-02-08 2005-03-16 Topotarget As Therapeutic compounds
WO2008022535A1 (fr) * 2006-08-09 2008-02-28 Tian Jin Tasly Group Co., Ltd. Composition pharmaceutique pour traiter le gliome du cerveau, son procédé et sa préparation pharmaceutique
CA2724384A1 (en) 2008-05-15 2009-11-19 Transmolecular, Inc. Treatment of metastatic tumors
DK2531206T3 (en) 2010-02-04 2017-09-11 Morphotek Inc CHLOROTOXIN POLYPEPTIDES AND CONJUGATES AND USE THEREOF
KR101972173B1 (ko) 2010-05-11 2019-04-24 프레드 헛친슨 켄서 리서치 센터 클로로톡신 변이체, 접합체, 및 이의 사용 방법
CN103169664B (zh) * 2011-12-25 2015-04-22 复旦大学 一种rgd肽修饰的双层载药纳米粒及其制备方法
CA2913029A1 (en) 2012-12-10 2014-06-19 Fred Hutchinson Cancer Research Center Lipocalin fusion partners
US11559580B1 (en) 2013-09-17 2023-01-24 Blaze Bioscience, Inc. Tissue-homing peptide conjugates and methods of use thereof
WO2017181149A1 (en) 2016-04-15 2017-10-19 Blaze Bioscience, Inc. Methods of treating breast cancer

Also Published As

Publication number Publication date
TW414710B (en) 2000-12-11
JPH08505615A (ja) 1996-06-18
CA2153775C (en) 2000-11-14
CZ286550B6 (cs) 2000-05-17
RU2148401C1 (ru) 2000-05-10
WO1994015615A1 (en) 1994-07-21
IL108328A0 (en) 1994-04-12
CN1117711A (zh) 1996-02-28
PL309915A1 (en) 1995-11-13
KR100352046B1 (ko) 2003-09-03
ZA94248B (en) 1994-07-13
NO952781L (no) 1995-09-13
FI953423A0 (fi) 1995-07-13
HU9502117D0 (en) 1995-09-28
CA2153775A1 (en) 1994-07-21
AU5838494A (en) 1994-08-15
HUT72665A (en) 1996-05-28
EP0679086A1 (en) 1995-11-02
UA29466C2 (uk) 2000-11-15
CZ179795A3 (en) 1996-04-17
PL175842B1 (pl) 1999-02-26
EP0922458A1 (en) 1999-06-16
SK89295A3 (en) 1996-06-05
KR960700063A (ko) 1996-01-19
IL108328A (en) 2010-05-31
MX9400434A (es) 1994-07-29
NO952781D0 (no) 1995-07-13
MY116474A (en) 2004-02-28
SK282452B6 (sk) 2002-02-05
CN1277541C (zh) 2006-10-04

Similar Documents

Publication Publication Date Title
FI953423A (fi) Temotsolomidin tehostaminen ihmisten kasvainsoluissa
NO942283L (no) Pyrofeoforbider og deres anvendelse i fotodynamisk terapi
FI954416A0 (fi) Kehon solujen stimulointi elektromagneettisen säteilyn avulla
BR9406209A (pt) Derivados heterociclicos no tratamento de isquemia e doenças relacionadas
PT1028954E (pt) Imidazoles substituidos uteis no tratamento de doencas inflamatorias
DE69433168D1 (de) In vitro vermehrung von stammzellen
IT1225148B (it) Liberazione prolungata e controllata di peptidi insolubili in acqua
EP0204597A3 (en) Use of alfuzosine in the treatment of urinary affections
NO982913D0 (no) Kinolin- og kinazolinforbindelser nyttige i terapi
HUP0100285A3 (en) Use of protein kinase c inhibitors to enhance the the clinical efficacy of oncolytic agents and radiation therapy
HUP9801634A3 (en) Genetically modified cells and their use in prevention or therapy of disease
IS5504A (is) Samsetning virk við meðhöndlun á getuleysi
DK295190D0 (da) Kosmetik- og hudbehandlingssammensaetninger
DE69331105D1 (de) Verwendung von thioureleyne und thiabendazol in auto immunbedingten und entzündlichen hauterkrankungen
NO970257D0 (no) Bestemmelse av tonisk ovarie-östrogen sekresjon i utvidede terapeutiske regimer
DE59306085D1 (de) Haar- und körperbehandlungsmittel
NO20010044L (no) Anvendelse av texafyriner i makrofag-medierte sykdommer
AU6371198A (en) Potentiation of temozolomide in human tumour cells
ITTO930699A0 (it) Procedimento per il trattamento e per la messa in forma dei capelli
SI1011649T1 (en) Use of endipalene in the treatment of psoriasis
FI924955A (fi) Expressionsvektorer och anvaendning av dessa foer producering av maenniskans HIV-resistenta celler foer terapeutiska aendmaol
SE8604881D0 (sv) Alkylglycerolernas effekt vid cancerterapi
IT1283937B1 (it) Procedimento per il trattamento dello stirene per ottenere caratteristiche di piroresistenza ed in particolare per il
NO903629D0 (no) Beskyttelse mot spredning av underlivssykdommer i boblebad
FI1035U1 (fi) Bil avsedd foer rullstolsbundna personer

Legal Events

Date Code Title Description
FD Application lapsed